Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 755

Results: 5

An open-label, randomized controlled trial to assess a ketogenic diet in critically ill patients with sepsis.
Published in:
Science Translational Medicine, 2024, v. 16, n. 755, p. 1, doi. 10.1126/scitranslmed.adn9285
By:
- Rahmel, Tim;
- Effinger, David;
- Bracht, Thilo;
- Griep, Leonore;
- Koos, Björn;
- Sitek, Barbara;
- Hübner, Max;
- Hirschberger, Simon;
- Basten, Jale;
- Timmesfeld, Nina;
- Adamzik, Michael;
- Kreth, Simone
Publication type:
Article
Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation.
Published in:
Science Translational Medicine, 2024, v. 16, n. 755, p. 1, doi. 10.1126/scitranslmed.adn0689
By:
- Zhu, Wenliang;
- Du, Wan;
- Rameshbabu, Arun Prabhu;
- Armstrong, Ariel Miura;
- Silver, Stewart;
- Kim, Yehree;
- Wei, Wei;
- Shu, Yilai;
- Liu, Xuezhong;
- Lewis, Morag A.;
- Steel, Karen P.;
- Chen, Zheng-Yi
Publication type:
Article
Hemodynamic evaluation of biomaterial-based surgery for Tetralogy of Fallot using a biorobotic heart, in silico, and ovine models.
Published in:
Science Translational Medicine, 2024, v. 16, n. 755, p. 1, doi. 10.1126/scitranslmed.adk2936
By:
- Singh, Manisha;
- Roubertie, François;
- Ozturk, Caglar;
- Borchiellini, Paul;
- Rames, Adeline;
- Bonnemain, Jean;
- Gollob, Samuel Dutra;
- Wang, Sophie X.;
- Naulin, Jérôme;
- El Hamrani, Dounia;
- Dugot-Senant, Nathalie;
- Gosselin, Isalyne;
- Grenet, Célia;
- L'Heureux, Nicolas;
- Roche, Ellen T.;
- Kawecki, Fabien
Publication type:
Article
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.
Published in:
Science Translational Medicine, 2024, v. 16, n. 755, p. 1, doi. 10.1126/scitranslmed.adg7123
By:
- Mog, Brian J.;
- Marcou, Nikita;
- DiNapoli, Sarah R.;
- Pearlman, Alexander H.;
- Nichakawade, Tushar D.;
- Hwang, Michael S.;
- Douglass, Jacqueline;
- Hsiue, Emily Han-Chung;
- Glavaris, Stephanie;
- Wright, Katharine M.;
- Konig, Maximilian F.;
- Paul, Suman;
- Wyhs, Nicolas;
- Ge, Jiaxin;
- Miller, Michelle S.;
- Azurmendi, Aitana;
- Watson, Evangeline;
- Pardoll, Drew M.;
- Gabelli, Sandra B.;
- Bettegowda, Chetan
Publication type:
Article
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system.
Published in:
Science Translational Medicine, 2024, v. 16, n. 755, p. 1, doi. 10.1126/scitranslmed.adg3456
By:
- Rosselot, Carolina;
- Li, Yansui;
- Wang, Peng;
- Alvarsson, Alexandra;
- Beliard, Kara;
- Lu, Geming;
- Kang, Randy;
- Li, Rosemary;
- Liu, Hongtao;
- Gillespie, Virginia;
- Tzavaras, Nikolaos;
- Kumar, Kunal;
- DeVita, Robert J.;
- Stewart, Andrew F.;
- Stanley, Sarah A.;
- Garcia-Ocaña, Adolfo
Publication type:
Article

Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 755

An open-label, randomized controlled trial to assess a ketogenic diet in critically ill patients with sepsis.

Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation.

Hemodynamic evaluation of biomaterial-based surgery for Tetralogy of Fallot using a biorobotic heart, in silico, and ovine models.

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system.